Skip to main content

JACKSON SQUARE CAPITAL, LLC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1812178 SAN FRANCISCO, CA

Position in CRVS

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$952,768
+$19,770 QoQ
Shares Held
63,773
0.0% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#78
of 172 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JACKSON SQUARE CAPITAL, LLC holds $952,768 across 1 Biotechnology name. CRVS ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRVS
Corvus Pharmaceuticals, Inc.
This page
63,773 $952,768

All Filings in CRVS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $952,768 63,773
2026-03-31 $932,998 63,773
2025-12-31 $491,052 63,773
2025-09-30 $470,007 63,773
2025-06-30 $255,092 63,773
2025-03-31 $202,798 63,773
2024-12-31 $341,185 63,773
2024-09-30 $336,721 63,773
2024-06-30 $116,066 63,773
2024-03-31 $113,515 63,773
2023-12-31 $112,240 63,773
2023-09-30 $93,108 63,773
2023-06-30 $146,040 63,773
2023-03-31 $58,033 63,773
2022-12-31 $54,207 63,773
2022-09-30 $52,230 63,773
2022-06-30 $63,135 63,773
2022-03-31 $104,587 63,773